These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2847540

  • 1. Regulation of 1,25 (OH)2D synthesis in hypoparathyroidism and pseudohypoparathyroidism.
    Breslau NA, Weinstock RS.
    Am J Physiol; 1988 Nov; 255(5 Pt 1):E730-6. PubMed ID: 2847540
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of dibutyryl cyclic adenosine 3',5'-monophosphate and parathyroid extract on calcium and phosphorus metabolism in hypoparathyroidism and pseudohypoparathyroidism.
    Bell NH, Avery S, Sinha T, Clark CM, Allen DO, Johnston C.
    J Clin Invest; 1972 Apr; 51(4):816-23. PubMed ID: 4335445
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of dibutyryl adenosine 3',5'-monophosphate administration on plasma concentrations of 1,25-dihydroxyvitamin D in pseudohypoparathyroidism type I.
    Yamaoka K, Seino Y, Ishida M, Ishii T, Shimotsuji T, Tanaka Y, Kurose H, Matsuda S, Satomura K, Yabuuchi H.
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1096-100. PubMed ID: 6270183
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Normal and abnormal regulation of 1,25-(OH)2D synthesis.
    Breslau NA.
    Am J Med Sci; 1988 Dec; 296(6):417-25. PubMed ID: 3063116
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The role of insulin in the stimulation of renal 1,25-dihydroxyvitamin D synthesis by parathyroid hormone in rats.
    Ikeda K, Matsumoto T, Morita K, Yamato H, Takahashi H, Ezawa I, Ogata E.
    Endocrinology; 1987 Nov; 121(5):1721-6. PubMed ID: 3311717
    [Abstract] [Full Text] [Related]

  • 13. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
    Portale AA, Booth BE, Halloran BP, Morris RC.
    J Clin Invest; 1984 Jun; 73(6):1580-9. PubMed ID: 6547151
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
    Stögmann W.
    Wien Klin Wochenschr Suppl; 1975 Jun; 33():1-15. PubMed ID: 176830
    [Abstract] [Full Text] [Related]

  • 16. Effect of parathyroid hormone on 1,25-dihydroxyvitamin D formation in type I pseudohypoparathyroidism.
    Aksnes L, Aarskog D.
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1223-6. PubMed ID: 6255001
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evidence for bone remodeling but lack of calcium mobilization response to parathyroid hormone in pseudohypoparathyroidism.
    Breslau NA, Moses AM, Pak CY.
    J Clin Endocrinol Metab; 1983 Sep; 57(3):638-44. PubMed ID: 6688258
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans.
    Portale AA, Halloran BP, Murphy MM, Morris RC.
    J Clin Invest; 1986 Jan; 77(1):7-12. PubMed ID: 3753709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.